Business Context and Reporting Period
Kura Oncology, Inc. filed a Form 8-K Current Report on August 1, 2015, regarding the entry into a material definitive agreement. The company is a Delaware corporation headquartered in La Jolla, California.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or overall debt levels. It specifically details the financial terms of a new office lease:
- Security Deposit: Approximately $44,000 paid upon execution.
- Initial Monthly Rent: Approximately $21,000.
- Lease Term: 60 months.
- Total Base Rent: $1.3 million over the lease period.
- Rent Escalation: 1.4% annual increase.
- Additional Obligations: Operating expenses, taxes, insurance, and utilities.
Material Changes
The company expanded its physical footprint by leasing approximately 3,677 square feet of office space at 55 Cambridge Parkway in Cambridge, Massachusetts. Possession of the premises was taken immediately upon the August 1, 2015 execution date.
Outlook and Risks
The filing does not provide updated financial guidance, management commentary on future performance, or specific risk factors beyond the contractual obligations of the lease. The lease agreement is subject to standard commercial terms including annual rent increases and additional operating costs.
Investor Verification Checklist
- Verify the impact of the $44,000 security deposit and future rent payments on the company's cash runway.
- Confirm the strategic rationale for establishing a presence in Cambridge, Massachusetts, relative to the company's clinical trial pipeline.
- Review the full lease agreement filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2015, for complete terms.